CJC-1295 With DAC – 100 Vials at 50% Off
2,36 €
Revo Peptide offers CJC-1295 With DAC at ≥99% purity, supplied as a lyophilized white powder in individual 2 mg vials — available here in a 100-vial bulk configuration at an exclusive 50% discount. This product is manufactured under strict quality control protocols and verified by HPLC and mass spectrometry prior to dispatch. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
CJC-1295 With DAC is a synthetic, long-acting growth hormone-releasing hormone (GHRH) analogue that has attracted significant interest in the peptide research community. The addition of a Drug Affinity Complex (DAC) technology component extends the molecule’s half-life considerably compared to its non-DAC counterpart, making it a compelling subject for studies examining sustained GHRH receptor engagement. Revo Peptide’s 100-vial bulk offering delivers outstanding value for laboratories and research institutions requiring consistent, high-volume supply of this compound at a verified ≥99% purity level.
Peptide Structure & Amino Acid Sequence
CJC-1295 With DAC is a 30-amino acid peptide with the following confirmed sequence:
H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
The molecular formula is C₁₅₂H₂₅₂N₄₄O₄₂ with a molecular weight of 3367.79 g/mol. The DAC moiety is covalently bonded to the lysine residue at position 12 (Lys¹²), enabling the peptide to bind reversibly to serum albumin in solution — a structural feature that underpins its extended plasma residence time and is a primary focus of ongoing in vitro and in vivo research.
Chemical & Physical Characteristics
- Appearance: White to off-white lyophilized powder
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: 3367.79 g/mol
- Solubility: Soluble in aqueous buffers and sterile water for laboratory reconstitution purposes
- Unit Size: 2 mg per vial
- Purity: ≥99% by HPLC
The lyophilized format preserves peptide integrity during transit and long-term storage, minimizing degradation risk and ensuring batch-to-batch consistency across the full 100-vial order.
Purity & Analytical Verification (HPLC & MS)
Every batch of CJC-1295 With DAC supplied by Revo Peptide undergoes rigorous analytical verification before release. High-performance liquid chromatography (HPLC) is used to confirm peptide purity at ≥99%, while mass spectrometry (MS) validates the molecular identity and confirms the correct molecular weight of 3367.79 g/mol. Certificate of Analysis (CoA) documentation is available upon request, providing full traceability for each production batch. Researchers can confidently integrate this compound into experimental workflows knowing that each vial meets the same exacting analytical standard.
Quality Control & Lyophilization Integrity
Revo Peptide applies pharmaceutical-grade lyophilization processes to all peptide products. The freeze-drying cycle is optimized to remove residual moisture while preserving the three-dimensional structure of the peptide. Each vial is sealed under inert conditions to prevent oxidation and contamination. The 100-vial bulk format undergoes the same quality control procedures as single-unit orders — no compromise is made on analytical standards or packaging integrity regardless of order volume.
Safety, Handling & Laboratory Precautions
CJC-1295 With DAC is supplied exclusively for in vitro and in vivo preclinical research applications. Laboratory personnel should handle this compound in accordance with standard biosafety protocols applicable to research-grade peptides. Appropriate personal protective equipment (PPE) — including gloves, lab coat, and eye protection — should be worn at all times during handling. Avoid inhalation of lyophilized powder. Dispose of all materials in compliance with local institutional and regulatory waste management guidelines. This compound has not been evaluated for safety or efficacy in humans or animals and must not be used outside of a controlled research environment.
Reconstitution, Packaging & Storage
Each vial contains 2 mg of lyophilized CJC-1295 With DAC. For laboratory reconstitution, researchers should follow their institution’s validated protocols using appropriate aqueous solvents such as sterile water or bacteriostatic water, depending on experimental design. Revo Peptide recommends storing lyophilized vials at -20°C for long-term stability. Once reconstituted, solutions should be stored at 4°C and used within a timeframe consistent with established research-grade peptide handling guidelines. Avoid repeated freeze-thaw cycles to maintain peptide integrity. The 100-vial bulk pack is designed for laboratory-scale procurement and includes secure, tamper-evident individual vial sealing.
Intended Research Use & Market Positioning
CJC-1295 With DAC is widely studied within the fields of endocrinology, metabolic research, and growth hormone biology. Its extended half-life profile — attributable to the DAC modification — makes it particularly relevant for researchers investigating sustained GHRH receptor activation kinetics, pulsatile growth hormone secretion modelling, and long-duration in vivo experimental designs. The 100-vial bulk configuration at 50% off is specifically structured for academic institutions, contract research organizations (CROs), and high-throughput research facilities that require reliable, cost-effective access to verified research peptides in volume.
Ordering, Availability & Fulfillment
Revo Peptide offers CJC-1295 With DAC – 100 Vials at 50% Off for sale online with streamlined ordering and prompt fulfillment. This bulk configuration represents one of the best-priced options available for high-purity CJC-1295 With DAC in the research peptide market. Order now to secure your supply at the discounted bulk rate. Our fulfillment team processes orders efficiently to minimize lead times for qualified research buyers. For volume inquiries or institutional procurement, contact Revo Peptide directly through our website.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 With DAC is sold exclusively as a laboratory research reagent. It has not been approved by the FDA or any equivalent regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals. Purchasers are solely responsible for ensuring compliance with all applicable local, state, federal, and international laws and regulations governing the purchase, possession, and use of research peptides. Revo Peptide makes no representations regarding the safety, efficacy, or suitability of this compound for any application beyond controlled laboratory research.
Related products
AC-262536 – 100 Bottles at 50% Off | Bulk Research Supply
Revo Peptide is proud to offer AC-262536 in a 100-bottle bulk configuration at an exceptional 50% discount — delivering outstanding value for high-volume research programs. Each bottle is supplied at 10 mg/mL concentration and verified at ≥98% purity through rigorous HPLC and mass spectrometry analysis. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Adipotide 10mg | 100 Vials – 50% Bulk Discount
Adipotide 10mg is a high-purity synthetic research peptide offered by Revo Peptide at ≥99% purity, verified by HPLC and mass spectrometry. This bulk 100-vial listing delivers exceptional value for qualified laboratory researchers seeking consistent, analytically verified material. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
AICA Ribonucleotide (AICAR) 50mg – 50 Vials at 30% Off
Revo Peptide offers AICA Ribonucleotide (AICAR) at ≥99% purity, supplied as lyophilized white powder in a convenient bulk vial format and verified by HPLC and mass spectrometry. This listing represents exceptional bulk value at 30% off standard pricing — ideal for high-throughput laboratory research programs. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
CJC-1295 No DAC & GHRP-2 Blend – 50 Vials at 30% Off
Revo Peptide's CJC-1295 No DAC & GHRP-2 Blend offers a convenient dual-peptide formulation at ≥98% purity, supplied in a 50-vial bulk configuration at an exceptional 30% discount. Each vial contains 2 mg of CJC-1295 No DAC and 2 mg of GHRP-2, totalling 4 mg of active peptide per vial. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
CJC-1295 No DAC & Ipamorelin Blend – 100 Vials at 50% Off
Revo Peptide's CJC-1295 No DAC & Ipamorelin Blend delivers 2 mg of each peptide per vial — 4 mg total — at ≥98% purity, verified by HPLC and mass spectrometry. This 100-vial bulk bundle is offered at 50% off, representing exceptional value for qualified research institutions and laboratories. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
CJC-1295 No DAC & Ipamorelin Blend – 50 Vials at 30% Off
Revo Peptide's CJC-1295 No DAC & Ipamorelin Blend delivers 2 mg of each peptide per vial — 4 mg total — at ≥98% purity, verified by HPLC and mass spectrometry. This bulk bundle of 50 vials is offered at 30% off the standard unit price, providing exceptional value for high-volume research programs. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
CJC-1295 No DAC 2mg & GHRP-2 Blend – 100 Vials at 50% Off
The CJC-1295 No DAC & GHRP-2 Blend from Revo Peptide delivers a co-lyophilized dual-peptide research reagent at ≥98% purity, with 2mg of each peptide per vial (4mg total) across a 100-vial bulk set at 50% off. Designed exclusively for laboratory research applications, this blend offers outstanding value for high-volume peptide research procurement. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Reviews
There are no reviews yet.